CliniMacs TCR alpha-beta-Biotin system for myelodysplastic syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Jan 2016: Trial registered, NCT02646839

The trials

NCT02646839: KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

State
Under way
Phase
Phase 2
People
50 planned
Started
Oct 2015
Primary completion
Nov 2025
Arms
KIR Favorable Transplant
Results
None posted
  1. 6 Jan 2016: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.